Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07117929

Effects of Pulsed Electromagnetic Field Therapy on Meniscal Healing, Symptom Relief, and Knee Function

Effects of Pulsed Electromagnetic Field Therapy on Meniscal Healing, Symptom Relief, and Knee Function in Patients With Isolated Meniscal Tears: A Randomized Controlled Trial

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
40 (estimated)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
All
Age
18 Years – 60 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to learn if pulsed electromagnetic field (PEMF) combined with home exercise improves healing and function in adults with meniscus tears. The main questions it aims to answer are: 1. Does PEMF therapy help heal meniscus tears, as seen on MRI scans? 2. Does PEMF therapy subjectively reduce knee pain, improve movement, and enhance quality of life? 3. Does PEMF therapy objectively help patients perform daily activities more easily? Researchers will compare PEMF therapy against a sham (inactive) treatment to determine if it provides additional benefits. Participants will: * Be assigned randomly to either the PEMF group (active treatment) or the sham PEMF group (inactive, but identical in appearance) * Receive either real PEMF therapy or sham treatment twice a week for 8 weeks (each session lasts 10 minutes). * Follow a standard home exercise program to strengthen their knees. * Have their knee function, pain levels, and healing progress checked through MRI scans, questionnaires, imaging and physical tests. * Return for 3 follow-up visits after the 8-week treatment period.

Conditions

Interventions

TypeNameDescription
DEVICEActive PEMFPEMF: 1.5mT, 10Hz, 10 minutes
DEVICESham PEMFPEMF 0mT, 0Hz, 10 minutes
OTHERExerciseStandardised home exercise protocol

Timeline

Start date
2025-08-15
Primary completion
2027-02-01
Completion
2027-08-01
First posted
2025-08-12
Last updated
2025-08-12

Locations

1 site across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT07117929. Inclusion in this directory is not an endorsement.